The CD8+PD‐1hi T cells located in the tumour tissue displayed a significantly higher clonality, with the top 30 clones contributing close to 90% of the entire T cell receptor repertoire compared with CD8+PD‐1neg T cells. Here, CD8A is linked to neoplasm.